The Clinical Intelligence Engine is capable of analysing vast...
Category:
Health
Latest
Budget-2023-24:Beyond tax-saving-driven insurance sales
Bhargav Dasgupta – MD & CEO, ICICI Lombard For a sector such as...
Study: Everyday well-being improved by good interaction with a friend
“The types of communication we chose to study were ones shown in...
Recoveries surge to 36 24 196 60 per cent of total recoveries concentrated in 5 states
Sixty per cent of the total recovered cases are being reported from five states – Maharashtra, Tamil Nadu, Andhra Pradesh, Karnataka and Uttar Pradesh, the ministry said on Saturday.
Vaccine likely in a few months, but life won’t return to normal until end of 2021:Dr. Fauci
“If you’re talking about getting back to a degree of normality which resembles where we were prior to Covid, it’s going to be well into 2021, maybe even towards the end of 2021,” he added.
Nearly 30 U.S. states are reporting downward trends in Covid-19 cases, but the pandemic will likely worsen again, said Fauci, the country’s leading infectious disease expert.
Record 96,551 COVID-19 new cases, tally crosses 45-lakh mark
The COVID-19 case fatality rate has further dropped to 1.67 per cent while the recovery rate was recorded at 77.65 per cent.
There are 9,43,480 active cases of COVID-19 in the country which comprises 20.68 per cent of the total caseload, the data stated.
India staring at another health disaster amid a raging battle with Covid-19
But the biggest crisis is India’s longstanding battle with tuberculosis. The country has as many as 2.7 million TB patients currently, by far the most in the world, and the disease kills an estimated 421,000 Indians each year. The current gap in care could lead to an additional 6.3 million cases and 1.4 million deaths from tuberculosis by 2025, according to a study by Zarir Udwadia, a pulmonologist at Mumbai’s P.D. Hinduja Hospital and Medical Research Centre.
AstraZeneca still aiming for Oxford Covid-19 vaccine by year-end:CEO
The pause highlights the importance of rigorous final-stage trials to pick up on potential side effects or rare events, according to Hatchett. It also shows the need to have a diversified portfolio of Covid-19 vaccines under development, a strategy that CEPI is using with its partners, he said.
“It points to the fact that vaccine development is tricky and unpredictable, and that things that look like they are going along very well can encounter difficulties,” he said.
IRDAI plans broad basing exclusive Carona covers, moots digital health insurance claim platform:Alamelu
“We are thinking of ways and means, sooner than later we will issue instructions on how standardised Covid-specific health insurance policies can be mainstreamed, renewed, features of porting migration so that Corona Rakshak and Corona Kavach policyholders continue to get a good cover not only for Covid but entire health sector.” said T.L. Alamelu,member (Non-Life),IRDAI on Friday while addressing an ASSOCHAM National e-Summit on Challenges, Opportunities & Way Forward for Health Insurance Under Covid Attack.
She also indicated that the regulator is currently is working on plans to develop a digital claim settlement mechanism involving all stakeholders – policyholders, insurers, TPAs, hospitals that could be stitched up with National Digital Health Mission.
Millions of COVID-19 cases went undetected in India, Research Paper Estimates
The research paper, written by government scientists and other experts and published late on Thursday, said large numbers of cases could have gone under the radar earlier this year because testing was limited to symptomatic patients or states had varying testing rates.
Munich Re to stop selling Pandemic Business Coverage after losses
“We are currently examining whether we will offer new contracts that include pandemic protection in property and casualty insurance in the future,” Torsten Jeworrek, Munich Re’s head of reinsurance, said in an interview.
“For the moment it has been suspended, for example with respect to event cancellations.” The company will continue to cover pandemics in its life and health contracts.Most of Munich Re’s Covid 19-related losses this year stemmed from the scrapping of major events and other hits to companies’ income during lockdown..
DCGI issues notice to Serum Institute over Oxford’s Covid trial suspension
“Whereas, Serum Institute of India Pvt Ltd, Pune, till now has not informed the Central licensing authority regarding pausing the clinical trial carried out by AstraZeneca in other countries and also not submitted casualty analysis of the reported serious adverse event with the investigational vaccine for the continuation of phase 2 and 3 clinical trials of the subject vaccine in the country in light of the safety concerns,” said the show-cause notice accessed by PTI.
Insurtech for assessing medical risk and cost of care raises $1.5mn
i3 Systems is an Indian AI product company for insurers, to estimate the medical risk and cost of care. The products work seamlessly on digital and unformatted data in complex healthcare and financial documents. The startup plans to use the funds to advance technology that enables seamless adoption of their product across all repetitive business processes in the BFSI industry.
Alok Agarwal, CFO, Reliance Industries and Zhooben Bhiwandiwala, president, Mahindra Partners are co-investors in i3 systems along with Unitus Ventures